1. Home
  2. ADT vs BIO Comparison

ADT vs BIO Comparison

Compare ADT & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADT
  • BIO
  • Stock Information
  • Founded
  • ADT 1874
  • BIO 1952
  • Country
  • ADT United States
  • BIO United States
  • Employees
  • ADT N/A
  • BIO N/A
  • Industry
  • ADT Diversified Commercial Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ADT Consumer Discretionary
  • BIO Industrials
  • Exchange
  • ADT Nasdaq
  • BIO Nasdaq
  • Market Cap
  • ADT 6.5B
  • BIO 6.9B
  • IPO Year
  • ADT 2018
  • BIO N/A
  • Fundamental
  • Price
  • ADT $7.87
  • BIO $238.18
  • Analyst Decision
  • ADT Buy
  • BIO Strong Buy
  • Analyst Count
  • ADT 4
  • BIO 4
  • Target Price
  • ADT $9.05
  • BIO $396.50
  • AVG Volume (30 Days)
  • ADT 18.4M
  • BIO 453.9K
  • Earning Date
  • ADT 04-24-2025
  • BIO 05-01-2025
  • Dividend Yield
  • ADT 2.80%
  • BIO N/A
  • EPS Growth
  • ADT 10.20
  • BIO N/A
  • EPS
  • ADT 0.53
  • BIO N/A
  • Revenue
  • ADT $4,898,446,000.00
  • BIO $2,566,500,000.00
  • Revenue This Year
  • ADT $5.36
  • BIO $0.88
  • Revenue Next Year
  • ADT $4.73
  • BIO $4.44
  • P/E Ratio
  • ADT $12.01
  • BIO N/A
  • Revenue Growth
  • ADT 5.28
  • BIO N/A
  • 52 Week Low
  • ADT $6.12
  • BIO $215.38
  • 52 Week High
  • ADT $8.39
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • ADT 49.81
  • BIO 44.44
  • Support Level
  • ADT $7.38
  • BIO $216.29
  • Resistance Level
  • ADT $8.20
  • BIO $252.41
  • Average True Range (ATR)
  • ADT 0.33
  • BIO 12.47
  • MACD
  • ADT -0.03
  • BIO 2.47
  • Stochastic Oscillator
  • ADT 48.51
  • BIO 61.57

About ADT ADT Inc.

ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: